Skip to main content Accessibility help
×
Hostname: page-component-77c89778f8-vsgnj Total loading time: 0 Render date: 2024-07-20T20:45:35.274Z Has data issue: false hasContentIssue false

8 - Managing Sedation, Orthostasis and Tachycardia

Published online by Cambridge University Press:  19 October 2021

Jonathan M. Meyer
Affiliation:
University of California, San Diego
Stephen M. Stahl
Affiliation:
University of California, San Diego
Get access

Summary

In 2016 the United States Food and Drug Administration (FDA) added the category of falls as subsection 5.9 of the Warnings and Precautions listings for all antipsychotic package inserts. This mandated language reflected the concept that changes in blood pressure or alertness may not meet criteria for orthostatic hypotension or sedation as an adverse event during clinical trials, yet together they increase the risk of falling. Increased fall risk, especially among older patients, is one concern related to sedation and orthostasis when starting clozapine, but the other concern is that a patient will find tiredness or dizziness unacceptable when commencing treatment and refuse to continue with clozapine. Using case register data from the South London and Maudsley National Health Service Foundation Trust, it was found that 45% of 316 new clozapine starts from 2007 to 2011 discontinued clozapine within 2 years of initiation. Moreover, 52% of the discontinuations were due to patient decision, and adverse drug reactions were 2.6 times more likely to be the cause than dislike of laboratory visits.

Type
Chapter
Information
The Clozapine Handbook
Stahl's Handbooks
, pp. 158 - 171
Publisher: Cambridge University Press
Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Legge, S. E., Hamshere, M., Hayes, R. D., et al. (2016). Reasons for discontinuing clozapine: A cohort study of patients commencing treatment. Schizophrenia Research, 174, 113119.Google Scholar
Ifteni, P., Nielsen, J., Burtea, V., et al. (2014). Effectiveness and safety of rapid clozapine titration in schizophrenia. Acta Psychiatrica Scandinavica, 130, 2529.CrossRefGoogle ScholarPubMed
Poyraz, C. A., Ozdemir, A., Saglam, N. G., et al. (2016). Rapid clozapine titration in patients with treatment refractory schizophrenia. Psychiatry Quarterly, 87, 315322.CrossRefGoogle ScholarPubMed
Nielsen, J., Correll, C. U., Manu, P., et al. (2013). Termination of clozapine treatment due to medical reasons: When is it warranted and how can it be avoided? Journal of Clinical Psychiatry, 74, 603613.CrossRefGoogle ScholarPubMed
Citrome, L., McEvoy, J. P. and Saklad, S. R. (2016). Guide to the management of clozapine-related tolerability and safety concerns. Clinical Schizophrenia & Related Psychoses, 10, 163177.Google Scholar
McEvoy, J. P., Lieberman, J. A., Stroup, T. S., et al. (2006). Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. American Journal of Psychiatry, 163, 600610.Google Scholar
Stroup, T. S., Lieberman, J. A., McEvoy, J. P., et al. (2009). Results of phase 3 of the CATIE schizophrenia trial. Schizophrenia Research, 107, 112.CrossRefGoogle ScholarPubMed
Subramanian, S., Vollm, B. A. and Huband, N. (2017). Clozapine dose for schizophrenia. Cochrane Database of Systematic Reviews, 6, Cd009555.Google Scholar
Perdigues, S. R., Quecuti, R. S., Mane, A., et al. (2016). An observational study of clozapine induced sedation and its pharmacological management. European Neuropsychopharmacology, 26, 156161.CrossRefGoogle Scholar
Srisurapanont, M., Suttajit, S., Maneeton, N., et al. (2015). Efficacy and safety of aripiprazole augmentation of clozapine in schizophrenia: A systematic review and meta-analysis of randomized-controlled trials. Journal of Psychiatric Research, 62, 3847.CrossRefGoogle ScholarPubMed
Takeuchi, H. and Remington, G. (2013). A systematic review of reported cases involving psychotic symptoms worsened by aripiprazole in schizophrenia or schizoaffective disorder. Psychopharmacology (Berlin), 228, 175185.Google Scholar
Kim, W., Tateno, A., Arakawa, R., et al. (2014). In vivo activity of modafinil on dopamine transporter measured with positron emission tomography and [(1)(8)F]FE-PE2I. International Journal of Neuropsychopharmacology, 17, 697703.CrossRefGoogle Scholar
Hannestad, J., Gallezot, J. D., Planeta-Wilson, B., et al. (2010). Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo. Biological Psychiatry, 68, 854860.CrossRefGoogle ScholarPubMed
Saavedra-Velez, C., Yusim, A., Anbarasan, D., et al. (2009). Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: A critical review. Journal of Clinical Psychiatry, 70, 104112.Google Scholar
Henderson, D. C., Freudenreich, O., Borba, C. P., et al. (2011). Effects of modafinil on weight, glucose and lipid metabolism in clozapine-treated patients with schizophrenia. Schizophrenia Research, 130, 5356.CrossRefGoogle ScholarPubMed
Andrade, C., Kisely, S., Monteiro, I., et al. (2015). Antipsychotic augmentation with modafinil or armodafinil for negative symptoms of schizophrenia: Systematic review and meta-analysis of randomized controlled trials. Journal of Psychiatric Research, 60, 1421.Google Scholar
Neto, D., Spinola, C. and Gago, J. (2017). Modafinil in schizophrenia: Is the risk worth taking? BMJ Case Reports, 2017,Google ScholarPubMed
Burke, M. and Sebastian, C. S. (1993). Treatment of clozapine sedation. American Journal of Psychiatry, 150, 19001901.Google ScholarPubMed
Skoretz, P. and Tang, C. (2016). Stimulants for impulsive violence in schizophrenia spectrum disordered women: A case series and brief review. CNS Spectrums, 21, 445449.Google Scholar
von Bahr, C., Lindstrom, B. and Seideman, P. (1982). Alpha-receptor function changes after the first dose of prazosin. Clinical Pharmacology and Therapeutics, 32, 4147.Google Scholar
Testani, M., Jr. (1994). Clozapine-induced orthostatic hypotension treated with fludrocortisone. Journal of Clinical Psychiatry, 55, 497498.Google Scholar
Ronaldson, K. J. (2017). Cardiovascular disease in clozapine-treated patients: Evidence, mechanisms and management. CNS Drugs, 31, 777795.CrossRefGoogle ScholarPubMed
Gupta, S. and Figueredo, V. M. (2014). Tachycardia mediated cardiomyopathy: Pathophysiology, mechanisms, clinical features and management. International Journal of Cardiology, 172, 4046.CrossRefGoogle ScholarPubMed
Zhang, D., Wang, W. and Li, F. (2016). Association between resting heart rate and coronary artery disease, stroke, sudden death and noncardiovascular diseases: A meta-analysis. CMAJ, 188, e384e392.CrossRefGoogle ScholarPubMed
Luo, S., Michler, K., Johnston, P., et al. (2004). A comparison of commonly used QT correction formulae: The effect of heart rate on the QTc of normal ECGs. Journal of Electrocardiology, 37(Suppl), 8190.CrossRefGoogle ScholarPubMed
Kim, D. D., White, R. F., Barr, A. M., et al. (2018). Clozapine, elevated heart rate and QTc prolongation. Journal of Psychiatry and Neuroscience, 43, 7172.CrossRefGoogle ScholarPubMed
Takeuchi, H., Powell, V., Geisler, S., et al. (2016). Clozapine administration in clinical practice: Once-daily versus divided dosing. Acta Psychiatrica Scandinavica, 134, 234240.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×